Using Online Delivered Therapy and Brain Imaging to Better Understand OCD
Using Electronically Delivered Cognitive Behavioural Therapy and Functional Magnetic Resonance Imaging to Understand the Pathophysiology of Obsessive-compulsive Disorder
1 other identifier
interventional
10
1 country
1
Brief Summary
This study will implement an e-CBT program for OCD and observe its effects on brain activation levels using functional magnetic resonance imaging (fMRI). It is hypothesized that brain activation levels in the basal ganglia and frontal cortex will decrease following treatment. Individuals with OCD will be offered a 16-week e-CBT program with ERP mirroring in-person CBT content that will be administered through a secure online platform. Efficacy of treatment will be evaluated using clinically validated symptomology questionnaires at baseline, week 8, week 16, and at a 6-month follow-up. Using fMRI at baseline and post-treatment, brain activation levels will be assessed at resting state, and while exposed to anxiety-inducing images (i.e., dirty dishes if cleanliness is an obsession). The effects of treatment on brain activation levels and the correlation between symptom changes and activation levels will be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2020
CompletedFirst Posted
Study publicly available on registry
November 16, 2020
CompletedStudy Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2022
CompletedDecember 27, 2023
December 1, 2023
1.4 years
November 5, 2020
December 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Changes in Brain Structure and Activation: Functional Magnetic Resonance Imaging (fMRI)
fMRI will be administered to observe any changes in structure.
Week 1, Week 16
Changes in symptoms: Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
Y-BOCS will be administered to analyze changes in symptoms from treatment. Scale of 0-4 for each question with 0 being no symptom severity and 4 being high symptom severity
Week 1, Week 8, Week 16, 6 Months
Changes in symptoms: Obsessive-Compulsive Inventory - Revised (OCI-R)
OCI-R will be administered to analyze changes in symptoms from treatment. Scale of 0-4 with 0 being not at all and 4 being extreme severity.
Week 1, Week 8, Week 16, 6 months
Changes in Quality of Life: Quality of Life and Enjoyment Questionnaire (Q-LES-Q)
Q-LES-Q will be administered to analyze changes in quality of life from treatment. Scale of 0-5 for each question with 0 being not at all and 5 being frequently
Week 1, Week 8, Week 16, 6 months
Changes in level of functioning: Sheehan Disability Scale (SDS0
SDS will be administered to analyze changes in levels of functioning. Scale of 0-10, 10 being the worst.
Week 1, Week 8, Week 16, 6 Months
Study Arms (1)
e-CBT
EXPERIMENTAL16 weekly sessions will be conducted through OPTT and consist of approximately 30 slides and interactive therapist videos. The content and format will mirror in-person CBT for OCD. The connection between thoughts, behaviours, emotions, physical reactions, and the environment will be a focus. Moreover, mindfulness, body scanning, self-care, goal setting, thinking errors, the 5-part model, thought records, and ERP will be incorporated. Slides will highlight different topics each week and include general information, an overview of skills, and homework on that topic. The homework will be submitted through OPTT and reviewed by therapists with personalized feedback provided within 3 days of submission. Weekly homework submission for feedback will be mandatory before being eligible for the next session. After each completion of the e-CBT program, participants will be interviewed to investigate their experience using OPTT and their perception of how the treatment went.
Interventions
Eligibility Criteria
You may qualify if:
- DSM-5 diagnosis of OCD made by a psychiatrist on the research team
- Competence to consent to participate
- Ability to speak and read English
- Consistent and reliable access to the internet
You may not qualify if:
- Metal implants
- Active psychosis
- Acute mania
- Severe alcohol or substance use disorder
- Active suicidal or homicidal ideation
- Receiving any additional form of psychotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Callum Stephensonlead
- Online PsychoTherapy Cliniccollaborator
Study Sites (1)
Queen's University
Kingston, Ontario, K7L 3N6, Canada
Related Publications (1)
Stephenson C, Malakouti N, Nashed JY, Salomons T, Cook DJ, Milev R, Alavi N. Using Electronically Delivered Therapy and Brain Imaging to Understand Obsessive-Compulsive Disorder Pathophysiology: Protocol for a Pilot Study. JMIR Res Protoc. 2021 Sep 14;10(9):e30726. doi: 10.2196/30726.
PMID: 34348889DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Callum Stephenson, BScH
Queen's University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principle Investigator, MSc Candidate
Study Record Dates
First Submitted
November 5, 2020
First Posted
November 16, 2020
Study Start
January 1, 2021
Primary Completion
June 1, 2022
Study Completion
July 28, 2022
Last Updated
December 27, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share
Only care providers involved in care of participants will have access to their information. Participants will only be identifiable by an ID number on the OPTT platform. Only anonymized data will be provided to the analysis team members. All data is encrypted by OPTT and no employee has direct access to patient data.